Article Detail - JF Part A

After careful consideration of all the feedback from interested parties regarding the MolDX: Molecular Testing for Solid Organ Allograft Rejection (DL38671) proposed local coverage determination (LCD), we have decided not to finalize the proposed LCD. In the coming months, we intend to issue a new proposed LCD and look forward to further public comment on this very important issue. The Medicare coverage database will be fully updated to reflect this decision next week.